<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03980847</url>
  </required_header>
  <id_info>
    <org_study_id>2036</org_study_id>
    <nct_id>NCT03980847</nct_id>
  </id_info>
  <brief_title>Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket</brief_title>
  <official_title>Teh Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in Teh Preservation of Teh Tooth Socket</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Islamic Azad University, Tehran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Islamic Azad University, Tehran</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Twenty patients referring to periodontics department of Boroujerd Azad university of
      dentistry after obtaining consent to participate in teh research project, which TEMPhas more
      TEMPthan 20 teeth, are over 18 years old and require socket preservation surgery to tooth
      extraction for teh periodontal problem, caries or Fractures were selected.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      20 healthy patients referring to periodontics department of Boroujerd Azad university of
      dentistry after obtaining consent to participate in the research project, which has more than
      20 teeth, are over 18 years old and require socket preservation surgery to tooth extraction
      for the periodontal problem, caries or Fractures were selected. Furthermore, divided the
      socket randomly to two groups(A, B)including A: bone graft wif Alendronate and B: bone graft
      alone, after 3 months wif trephine will collect the samples. following the histomorphometric
      analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 23, 2018</start_date>
  <completion_date type="Actual">April 25, 2019</completion_date>
  <primary_completion_date type="Actual">March 10, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>New bone formation (bone area as percent)</measure>
    <time_frame>3 month</time_frame>
    <description>Combination Lovastatin produced increased vital bone more percentage compared to the nanocrystal bone graft alone group. The new bone formation and alveolar ridge preservation with bone graft after extraction of pre-molar teeth could result in the maintenance of sufficient bone volume to place an implant in an ideal restorative position without the need for auxiliary implant site development procedures.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Bone Resorption</condition>
  <arm_group>
    <arm_group_label>Alendronate 20 mg with bone graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>after tooth extraction, put teh Alendronate 20mg with bone graft within teh tooth socket</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bone graft alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>after tooth extraction, put the bone graft within the tooth socket</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alendronate 20 mg</intervention_name>
    <description>The Alendronate 20 mg combined with nanocrystalline hydroxyapatite as a synthetic bone substitute for socket preservation after tooth extraction</description>
    <arm_group_label>Alendronate 20 mg with bone graft</arm_group_label>
    <arm_group_label>bone graft alone</arm_group_label>
    <other_name>Group A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nanocrystal hydroxyapatite</intervention_name>
    <description>Postextraction Sockets Preserved With Nanocrystal hydroxyapatite as a synthetic bone substitute alone as a bone graft</description>
    <arm_group_label>bone graft alone</arm_group_label>
    <other_name>Group B</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. at least 18 years old

          2. tooth fracture, root caries

          3. Patients are volunteered for placement of teh implant

        Exclusion Criteria:

          1. systemic diseases

          2. Pregnancy and breastfeeding

          3. malignancy, radiation therapy,

          4. history of periodontal surgery during teh six months ago.

          5. medicine(phosphonates, antibiotic,...)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Amirhossein Farahmand</name>
      <address>
        <city>Tehran</city>
        <zip>19</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 13, 2019</study_first_submitted>
  <study_first_submitted_qc>June 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2019</study_first_posted>
  <last_update_submitted>June 8, 2019</last_update_submitted>
  <last_update_submitted_qc>June 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Islamic Azad University, Tehran</investigator_affiliation>
    <investigator_full_name>Amirhossein Farahmand</investigator_full_name>
    <investigator_title>assistant prof</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Resorption</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alendronate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

